Skip to main content

Weight Loss in a Unique Way

e-pharmatimes-weight-loss

Weight Loss

Hello everybody, today I am coming up with a post which probably many of us will like, its about "Weight Loss".

Most of us actually plan out for weight loss or prepare a wish list about weight loss diet. But in practice we generally do not go with it, and finally end up in weight gain. But there are some revolutionary ways to cut down weight or burn out calories by going with some complicated medical procedures like LIPOSUCTION, which actually is not a healthy practice. When one can control the body weight by following simple daily physical work outs and a planned diet, there wont be a dire need for medical procedures to come in to cut off the excess fats in our body. So Readers , now I guess you understood how can one bring down his weight by simple physical activities.

Plan  your plate with a complete and balanced nutrition and this will autopilot your weight.


Join and Like our Facebook page: ePharmatimes @ Facebook

Comments

Popular posts from this blog

Intellectual Property Rights and Portfolio Management in Pharmaceuticals

  Introduction The pharmaceutical industry depends heavily on intellectual property (IP) rights to stay innovative and competitive. Without these protections, companies risk losing the chance to profit from their discoveries. Managing a strong IP portfolio helps maximize research and development (R&D) investments, open doors to licensing deals, and keep drugs on the market longer. Still, this field faces many hurdles, including tough patent laws worldwide and changing regulations. At the same time, emerging opportunities can give companies a competitive edge if they master IP management. Understanding Intellectual Property Rights in Pharmaceuticals What Are Intellectual Property Rights? IP rights are legal tools that protect creations and ideas. In pharma, they help companies control and profit from their inventions for a certain time. Types of IP relevant to drugs include patents, trademarks, trade secrets, and data exclusivity. Each has a role in defending the company’s i...

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...

An Overview of Brazil Patent litigation

  An Overview of Brazil Patent litigation Brazil plays a crucial role in Latin America's intellectual property landscape, particularly when it comes to patent litigation. The country's strong legal framework, governed by the Industrial Property Act, creates an environment where patents can be protected and enforced effectively. The Brazilian patent system serves as a vital mechanism for: Protecting innovative technologies Securing market advantages Fostering economic development Promoting technological advancement For businesses and inventors, understanding Brazil's patent litigation system is essential for success in this emerging market. The system's unique characteristics, including its bifurcated approach to handling infringement and invalidity cases, create distinct challenges and opportunities. Recent years have witnessed a surge in patent litigation cases, particularly in: Pharmaceutical sectors Technology industries Telecommunications Manufacturing This increa...